QSS
CRL icon

Quantitative Systematic Strategies’s Charles River Laboratories CRL Stock Holding History

Quantitative Systematic Strategies’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,922
Closed -$1.45M – 93
2021
Q2 		$1.45M Sell
3,922
-16,290
-81% -$5.44M 0.51% 24
2021
Q1 		$5.86M Sell
20,212
-3,186
-14% -$886K 0.91% 3
2020
Q4 		$5.85M Buy
23,398
+9,302
+66% +$2.22M 0.83% 5
2020
Q3 		$3.19M Sell
14,096
-5,983
-30% -$1.24M 0.56% 34
2020
Q2 		$3.5M Buy
20,079
+14,080
+235% +$2.25M 0.69% 12
2020
Q1 		$757K Buy
+5,999
New +$900K 0.62% 44
2019
Q4 		– Sell
-12,763
Closed -$1.69M – 561
2019
Q3 		$1.69M Buy
12,763
+5,224
+69% +$700K 0.39% 80
2019
Q2 		$1.07M Buy
+7,539
New +$1.02M 0.2% 148
2018
Q1 		– Sell
-2,829
Closed -$310K – 646
2017
Q4 		$310K Buy
+2,829
New +$308K 0.08% 375

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Quantitative Systematic Strategies's CRL Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Charles River Laboratories (CRL) in Q3 2021, closing a stake of 3,922 shares — an estimated $1.45M sold.

Quantitative Systematic Strategies first reported a position in CRL in Q4 2017 and held it in 9 quarters. The position peaked at $5.86M in Q1 2021. 676 funds tracked by Wall St. Rank hold CRL as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Charles River Laboratories position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 3,922 Charles River Laboratories shares in Q3 2021, an estimated $1.45M.
  • Quantitative Systematic Strategies first reported a position in Charles River Laboratories in Q4 2017 and held it in 9 quarters.
  • Quantitative Systematic Strategies's Charles River Laboratories position peaked at $5.86M in Q1 2021.
  • 676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.